
Permanence Bio provides an AI-powered platform to prevent cancer by reducing DNA-damaging mutations. It designs therapeutics using AI, genomics, and protein engineering to block cancer-causing pathways. The product targets partners in pharma and biotech, placing it in the B2B biotech space. Core technologies include AI-driven design, genomic analytics, and DNA damage modeling, with integrations to standard lab workflows.

Permanence Bio provides an AI-powered platform to prevent cancer by reducing DNA-damaging mutations. It designs therapeutics using AI, genomics, and protein engineering to block cancer-causing pathways. The product targets partners in pharma and biotech, placing it in the B2B biotech space. Core technologies include AI-driven design, genomic analytics, and DNA damage modeling, with integrations to standard lab workflows.